732
Participants
Start Date
April 25, 2025
Primary Completion Date
March 1, 2027
Study Completion Date
September 1, 2027
Neuronavigation-assisted Stereotactic Minimally Invasive Puncture Combined with Tenecteplase
Neuronavigation-assisted stereotactic minimally invasive puncture will enhances catheter placement precision, reducing complications and improving hematoma evacuation and neurological outcomes. TNK, a third-generation thrombolytic will offers advantages over alteplase (rt-PA), including a longer half-life for rapid bolus administration and effective thrombolytic effects to dissolve clots and promote hematoma clearance.
Standard medical treatment
The standard medical treatment for this group of patients will be provided according to the optimal care standards defined by the American Heart Association (AHA) guidelines for intracerebral hemorrhage management
RECRUITING
Beijing Tiantan Hospital, Beijing
Beijing Tiantan Hospital
OTHER